The influence of long-term hormonal contraception and smoking on plasma concentrations of nitrites and nitrates

Medical Science Monitor

Volumn 11, Issue 2, 2005, Pages

  Alušík, Štefan ^a   Paluch, Zoltan ^a   Jedličková, Věra ^a  

^a FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

Author keywords

Cigarette smoking; Hormonal contraception; Nitric oxide; Nitrites nitrates

Indexed keywords

ETHINYLESTRADIOL; NITRATE; NITRIC OXIDE; NITRITE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HORMONAL CONTRACEPTION; HUMAN; MEASUREMENT; NORMAL HUMAN; PREMENOPAUSE; STATISTICAL SIGNIFICANCE;

ADULT; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; NITRATES; NITRITES; RETROSPECTIVE STUDIES; SMOKING; TIME FACTORS;

EID: 13844270790     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mendelsohn ME: Protective effects of estrogen on the cardiovascular system. Am J Cardiol, 2002; 89(Suppl): 12E-18E
2. Sader MA, Celermajer DS: Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res, 2002; 53: 597-604
3. Stefano GB, Peter D: Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications. Med Sci Monit, 2001; 7: 1066-74
4. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case control study. Lancet, 1997; 349: 1202-9
5. Lewis MA, Heinemann LA, Spitzer WO et al: The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception, 1997; 56: 129-40
6. Mant J, Painter R, Vessey M: Risk of myocardial infarction, angina, and stroke in users of oral contraceptives: an updated analysis of a cohort study. Br J Obstet Gynaecol, 1998; 105: 890-96
7. Dunn N, Thorogood M, Faragher B et al: Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ, 1999; 318: 1579-83
8. Sidney S, Siscovick DS, Petitti DB et al: Myocardial Infarction and Use of Low-Dose Oral Contraceptives. A Pooled Analysis of 2 US Studies. Circulation, 1998; 98: 1058-63
9. Rosenberg L, Palmer JR, Lesko SM, Shapiro S: Oral contraceptive use and the risk of myocardial infarction. Am J Epidemiol, 1990; 131: 1009-16
10. Croft P, Hannaford PC: Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. BMJ, 1989; 298: 165-68
11. Rosenberg L, Kaufman DW, Helmrich SP et al: Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA, 1985; 253: 2965-69
12. Thorogood M, Mann J, Murphy M, Vessey M: Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Br J Obstet Gynaecol, 1991; 98: 1245-53
13. Sidney S, Petitti DB, Quesenberry CP Jr et al: Myocardial infarction in users of low- dose oral contraceptives. Obstet Gynecol, 1996; 88: 939-44
14. Ellis G, Adatia I, Yazdanpanah M, Makela SK: Nitrite and Nitrate Analyses: A Clinical Biochemistry Perspective. Clin Biochem, 1998; 31: 195-220
15. Preik-Steinhoff H, Kelm M: Determination of nitrite in human blood by combination of a specific sample preparation with high-performance anion-exchange chromatography and electrochemical detection. J Chromatogr B, 1996; 685: 348-52
16. Jedličková V, Paluch Z, Alušík Š: Determination of nitrate and nitrite by high-performance liquid chromatography in human plasma. J Chromatogr B, 2002; 780: 193-97
17. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM et al: Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet, 1995; 346: 1593-96
18. World Health Organization: Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet, 1995; 346: 1582-88
19. Jick H, Jick SS, Gurewich V et al: Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with different progestagen components. Lancet, 1995; 346: 1589-93
20. Hayashi T, Yamada K, Esaki T et al: Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun, 1995; 214: 847-55
21. Peek J, Markham R, Fraser IS: The effects of natural and synthetic sex steroids on human decidual endothelial cell proliferation. Hum Reprod, 1995; 10: 2238-43
22. Subakir SB, Hadisaputra W, Siregar B et al: Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception. Hum Reprod, 1995; 10: 2579-83
23. John S, Jacobi J, Schlaich MP et al: Effects of oral contraceptives on vascular endothelium in premenopausal women. Am J Obstet Gynecol, 2000; 183: 28-33
24. Merki-Feld GS, Rosselli M, Dubey RK et al: Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women. Contraception, 2002; 65: 231-36
25. McLeod TM, López-Figueroa AL, López-Figueroa AL: Nitric oxide, stress, and depression. Psychopharmacol Bull, 2001; 35: 24-41
26. Esch T, Stefano GB, Fricchione G, Benson H. Stress-related diseases - a potential role for nitric oxide. Med Sci Monit, 2002; 8: 103-118
27. Node K, Kitakaze M, Yoshikawa H et al: Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol, 1997; 79: 1538-41
28. Jeerooburkhan N, Jones LC, Bujac S et al: Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension, 2001; 38: 1054-61.